Reckitt Benckiser Pharmaceuticals Inc

Type: Company
Name: Reckitt Benckiser Pharmaceuticals Inc
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

Court Report - September 2014 #6

About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases .Cadence Pharmaceuticals Inc. et al. v. InnoPharma Licensing LLC et al.1:14-cv-01225; filed September 24, 2014 in the District Court of Delaware• Plaintiffs:  ... [Published JD Supra - Sep 29 2014]
First reported Sep 15 2014 - Updated Sep 16 2014 - 1 reports

Medication 50 Times Stronger Than Morphine Dangerously Within Reach For Kids

Prescription painkiller and heroin addiction has laced its way through America, and effective anti-addiction treatments line the medicine cabinets of thousands of homes. Government researchers have discovered though drug treatment is effective in assisting ... [Published Medical Daily - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Study: Kids' emergency hospitalizations tied to anti-addiction drug; packaging change may help

, EDT.FILE - In this March 11, 2013 file photo, Shavonne Bullock, a recovering heroin addict, holds a demonstration dose of the medication Suboxone during an appointment at the West Division Family Health Center in Chicago. Each dose is incorporated on ... [Published 580 CFRA - Sep 15 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

XenoPort to Present at the Morgan Stanley Global Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)-- XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Morgan Stanley Global Healthcare Conference. The live presentation will occur at 1:40 p.m. ... [Published CNBC - Sep 02 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Pharmacist Develops Naloxone Nasal Spray to Reverse Drug Overdoses

Krystle VermesPublished Online: Wednesday, August 27, 2014Follow Pharmacy_Times:A pharmacy professor at the University of Kentucky has developed a nasal spray of naloxone (Narcan) to treat potentially fatal overdoses from heroin and prescription opio ... [Published Pharmacy Times - Aug 27 2014]
First reported May 21 2014 - Updated May 21 2014 - 1 reports

AntiOp Partners with Reckitt Benckiser Pharmaceuticals, Inc. to Develop Nasally Administered Treatment for Opioid Overdose

LEXINGTON, Ky.--(BUSINESS WIRE)--AntiOp, Inc. has signed an agreement with Reckitt Benckiser Pharmaceuticals, Inc. to accelerate production and worldwide marketing of intranasal naloxone, a drug designed to treat opioid overdose. ... [Published Business Wire Health News - May 21 2014]

Quotes

Infringement of U S Patent Nos. 6,028,222 ( "Stable Liquid Paracetamol Compositions, and Method for Preparing the Same" issued February 22, 2000) and 6,992,218 ("Method for Obtaining Aqueous Formulations of Oxidation-Sensitive Active Principles," issued January 31, 2006)...
"You can fill a prescription at one of our pharmacies and have this in your home if you have an at-risk family member" Dr. Wermeling told the Lexington Herald-Leader

More Content

All (8) | News (5) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
Court Report - September 2014 #6 [Published JD Supra - Sep 29 2014]
Medication 50 Times Stronger Than Morphine Dang... [Published Medical Daily - Sep 15 2014]
Study: Kids' emergency hospitalizations tied to... [Published 580 CFRA - Sep 15 2014]
XenoPort to Present at the Morgan Stanley Globa... [Published CNBC - Sep 02 2014]
Pharmacist Develops Naloxone Nasal Spray to Rev... [Published Pharmacy Times - Aug 27 2014]
AntiOp Partners with Reckitt Benckiser Pharmace... [Published Business Wire Health News - May 21 2014]
Reckitt Benckiser Pharmaceuticals Inc. Enters I... [Published Financial Services - May 19 2014]
Reckitt Benckiser Pharmaceuticals and XenoPort ... [Published Financial Services - May 15 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
AntiOp Partners with Reckitt Benckiser Pharmace... [Published Business Wire Health News - May 21 2014]
LEXINGTON, Ky.--(BUSINESS WIRE)--AntiOp, Inc. has signed an agreement with Reckitt Benckiser Pharmaceuticals, Inc. to accelerate production and worldwide marketing of intranasal naloxone, a drug designed to treat opioid overdose. ...
1

Press Releases

sort by: Date | Relevance
Reckitt Benckiser Pharmaceuticals Inc. Enters I... [Published Financial Services - May 19 2014]
Reckitt Benckiser Pharmaceuticals and XenoPort ... [Published Financial Services - May 15 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.